Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study [Hematologic Malignancy]

Conclusion
Post-transplantation survival in AL has improved, with a dramatic reduction in early post-transplantation mortality and excellent 5-year survival. The risk-benefit ratio for autotransplantation has changed, and randomized comparison with nontransplantation approaches is again warranted.

Source: Journal of Clinical Oncology - November 6, 2015 Category: Cancer & Oncology Authors: D'Souza, Dispenzieri, Wirk, Zhang, Huang, Gertz, Kyle, Kumar, Comenzo, Peter Gale, Lazarus, Savani, Cornell, Weiss, Vogl, Freytes, Scott, Landau, Moreb, Costa, Ramanathan, Callander, Kamble, Olsson, Ganguly, Nishihori, Kindwall-Keller, Wood, Mark, Hari Tags: Myeloma Hematologic Malignancy Source Type: research